Commodore Capital LP Cogent Biosciences, Inc. Transaction History

Commodore Capital LP

$998 Million
Q4 2024

A detailed history of Commodore Capital LP transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 6,881,629 shares of COGT stock, worth $55.7 Million. This represents 5.38% of its overall portfolio holdings.

Number of Shares

6,881,629

Previous 7,539,930 8.73%

Holding current value

$55.7 Million

Previous $81.4 Million 34.08%

% of portfolio

5.38%

Previous 6.92%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.64 - $12.28 $5.03 Million - $8.08 Million	-658,301 Reduced 8.73%	6,881,629 $53.7 Million
Q3 2024 Nov 14, 2024	SELL	$8.24 - $11.48 $18.1 Million - $25.2 Million	-2,198,070 Reduced 22.57%	7,539,930 $81.4 Million
Q2 2024 Aug 14, 2024	BUY	$6.01 - $9.04 $19.9 Million - $29.9 Million	3,313,000 Added 51.56%	9,738,000 $82.1 Million
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $3.76 Million - $7.75 Million	858,974 Added 15.43%	6,425,000 $43.2 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $7.82 Million - $10.5 Million	793,605 Added 16.63%	5,566,026 $65.9 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $4.54 Million - $7.01 Million	452,481 Added 10.47%	4,772,421 $51.5 Million
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $5.87 Million - $10.6 Million	-624,768 Reduced 12.64%	4,319,940 $64.5 Million
Q2 2022 Aug 15, 2022	BUY	$3.92 - $9.73 $5.66 Million - $14 Million	1,443,940 Added 41.25%	4,944,708 $44.6 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.7 $6.48 Million - $10.6 Million	1,219,453 Added 53.45%	3,500,768 $26.2 Million
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $2.77 Million - $3.99 Million	368,804 Added 19.28%	2,281,315 $19.6 Million
Q3 2021 Nov 15, 2021	BUY	$5.99 - $9.14 $3.26 Million - $4.98 Million	544,929 Added 39.85%	1,912,511 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.3 $769,386 - $914,999	98,387 Added 7.75%	1,367,582 $11.1 Million
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $3.8 Million - $6.28 Million	509,170 Added 66.99%	1,269,195 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $6.87 Million - $9.89 Million	760,025 New	760,025 $8.54 Million

Others Institutions Holding COGT

# of Institutions

190

Shares Held

104M

Call Options Held

157K

Put Options Held

439K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $532M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Account

Commodore Capital LP Cogent Biosciences, Inc. Transaction History